The QualityStocks Daily Tuesday, March 24th, 2020

Today's Top 3 Investment Newsletters

MarketClub Analysis (ASTC) +261.61%

StockMarketWatch (MFA) +216.67%

QualityStocks (GTCH) +107.14%

The QualityStocks Daily Stock List

Baristas Coffee Company, Inc. (BCCI)

Small Cap Network, Zacks, MJ Global Report, Emerging Growth, MacroTrends, Macroaxis, Research Pool, Seeking Alpha, Street Insider, OTC Markets, TipRanks, Proactive Investors, Insider Financial, InvestorsHub, Investors Hangout, Central Charts and Spotlight Growth reported earlier on Baristas Coffee Company, Inc. (BCCI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A national coffee company, Baristas Coffee Company, Inc. develops and markets primarily coffee related products. It partnered with Amazon to offer the only White Coffee single serve cups compatible with the Keurig® K-Cup® Brewing System 2.0. At present, the Company produces and sells coffee related products under the Baristas brand. Baristas Coffee Company has its head office in Kent, Washington.

The Baristas White Coffee single-serve cups compatible with the Keurig 2.0 brewing system is the bestselling product in its category. In addition, Baristas sells CBD (cannabidiol) infused coffee under the EnrichaRoast CBD brand. It also markets other coffee-related products. Amazon Prime has Baristas Coffee products available throughout Canada. The products sold by Baristas and fulfilled by Amazon available in Canada include White Coffee and Espresso Roast single-serve pods compatible with the Keurig 2.0 brewing system, and Baristas Ground White Coffee. Other products are being added now that Canada is part of Baristas distribution territory.

Baristas Coffee Company announced in October 2019 that it entered into a Ben & Jerry’s partnership agreement with Unilever and Ice Cream Now to develop and implement a network to deliver Ben and Jerry’s ice cream and Baristas Coffee products to homes and businesses throughout the U.S. The program began to rollout in November 2019 initially in the Seattle, Washington area centering on the “couch moments” when consumers most order desserts and the “craving coffee” periods. Ben & Jerry’s manufactures ice cream, frozen yogurt and sorbet. Unilever is a consumer goods company. Its products include food and beverages, cleaning agents, beauty products, and personal care products.

This past January, Baristas Coffee Company announced that its new coffee entitled "Baristas Harmony" is now available as a specialty product on Amazon Prime with free delivery. Harmony blends white and black coffee equally creating a smooth blend encompassing the robust flavor of its Espresso Roast with the smooth nutty flavor of its White Coffee with a kick.

This month, Baristas Coffee Company/Munchie Magic announced that it created a separate company Munchie Magic, Inc. Munchie Magic will focus exclusively on the development and expansion of the Munchie Magic virtual restaurants that delivers Ben & Jerry's ice cream along with Baristas coffee products and other snacks foods via its third-party delivery partners.

Baristas Coffee Company remains the majority shareholder. Furthermore, it maintains control of the Board of Directors, and will be able to report revenues in its financial statements based on consolidated financial statement principles. The purposes for establishing the separate company included, but were not limited to, clarity in accounting, the ability to fund the expansion of the business, ease of separating Munchie Magic from other Baristas activities, and avoidance of potential confusion in the marketplace.

Baristas Coffee Company, Inc. (BCCI), closed Wednesday's trading session at $0.01, off by 8.2569%, on 374,350 volume with 17 trades. The average volume for the last 3 months is 544,898 and the stock's 52-week low/high is $0.008399999/$0.043999999.

chart

Concrete Pumping Holdings, Inc. (BBCP)

StockTrends, MacroTrends, GlobeNewswire, Zacks, Market Screener, Street Insider, TipRanks, Barchart, last10k, Stockhouse, Morningstar, Simply Wall St, Market Chameleon, Stockopedia, GuruFocus, Invest Chronicle, Investors Hangout, YCharts, Seeking Alpha, Investor Welcome, Stock Jump, News Welcome, ChartMill and ETF.com reported previously on Concrete Pumping Holdings, Inc. (BBCP), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Concrete Pumping Holdings, Inc. is a foremost provider of concrete pumping services and concrete waste management services in the United States and the United Kingdom. The Company mainly operates under what it believes are the only established, national brands in both geographies – Brundage-Bone for concrete pumping in the United States, Camfaud in the United Kingdom and Eco-Pan for waste management services in the U.S. and the U.K. Established in 1983, Concrete Pumping Holdings has its corporate headquarters in Thornton, Colorado.

Concrete pumping is a "mission-critical" method of concrete placement. It requires highly-skilled operators to position a truck-mounted fully-articulating boom for precise delivery of ready-mix concrete from mixer trucks to placing crews on a job site.

Concrete Pumping has a large fleet of specialized pumping equipment and trained operators. These position it to deliver concrete placement solutions that facilitate considerable labor cost savings to customers, shorten concrete placement times, enhance worksite safety and improve construction quality.

Concrete Pumping, through Eco-Pan, is also the top provider of concrete waste management services in the U.S. market. Highly complementary to the Company’s core concrete pumping service, Eco-Pan provides a full-service, cost-effective, regulatory-compliant solution to manage environmental issues caused by concrete washout. Eco-Pan specializes in concrete cleanup and disposal services across the country.

Brundage-Bone is the largest concrete pumping and material placement service provider in the U.S. Camfaud is the largest concrete pumping and material placement service provider in the U.K. As of January 31, 2020, Concrete Pumping provided concrete pumping services in the U.S. from a footprint of roughly 90 locations across 22 States, concrete pumping services in the U.K. from 28 locations, and route-based concrete waste management services from 16 locations in the U.S. and 1 location in the U.K.

This month, Concrete Pumping Holdings reported financial results for its Q1 ended January 31, 2020. Selected highlights include Consolidated Revenue rising 27 percent to $73.9 million. Gross Margin increased 370 basis points to 43.5 percent. Net Loss Attributable to Common Shareholders improved to $3.2 million or $(0.06) per diluted share versus a Net Loss of $26.6 million in Q1 of fiscal year 2019.

Mr. Bruce Young, Chief Executive Officer of Concrete Pumping Holdings, said, “Our first quarter results continued the momentum of fiscal 2019, with our 27 percent revenue growth flowing through to a 39 percent increase in Adjusted EBITDA. We continue to benefit from the synergies and margin enhancements of last year’s Capital Pumping acquisition, as well as a strong U.S. operating environment and continued success with Eco-Pan. In addition, most of our U.S. regional markets generated top-line growth this quarter, which highlights the long-term resilience of our business.”

Concrete Pumping Holdings, Inc. (BBCP), closed Wednesday's trading session at $3.51, off by 1.1268%, on 76,439 volume with 477 trades. The average volume for the last 3 months is 91,093 and the stock's 52-week low/high is $2.42000007/$10.0291004.

chart
n

Critical Elements Lithium Corporation (CRECF)

Midas Letter, Energy and Capital, GuruFocus, PR Newswire, Miningandenergy.ca, Stockhouse, Investor Intel, Investing News, Morningstar, Junior Mining Network, Seeking Alpha, Equities.com, Mining Stock Education, SmallCapPower, Geology for Investors, Mining.com, Nasdaq, GlobeNewswire, OTC.Watch, TradingView, InvestorsHub and Simply Wall St reported previously on Critical Elements Lithium Corporation (CRECF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Critical Elements Lithium Corporation is a junior mining company in advanced exploration stage. The Company’s flagship project is the Rose Lithium-Tantalum project situated in James Bay, Quebec. Critical Elements Lithium owns several mining properties in Quebec and its focus is lithium. The Company formerly went by the name Critical Elements Corporation. It changed its name to Critical Elements Lithium Corporation in June of 2019. The Company is headquartered in Montreal, Quebec and lists on the OTC Markets Group’s OTCQX.

The Rose Lithium-Tantalum project has a good geographic location and on-site access to infrastructures including powerline, roads, airport, railway access and camp. The Rose property comprises 473 claims spread over a 24,654.81 ha area. Based on the work programs developed and positive results, Critical Elements Lithium is working to put the Rose Lithium-Tantalum project into production speedily. Currently, the Rose Lithium-Tantalum Project contains reserves of 26,8 million tonnes of Probable Reserves at a grade of 0.96% Li2O Eq. or 0.85% Li2O and 133 ppm Ta2O5.

The Company’s near-term emphasis is on securing final permits and project financing with first production targeted for 2021. The Rose Lithium-Tantalum project is on track to be fully permitted this year. Rose is the only new source of technical grade lithium worldwide.

At present, Critical Elements Lithium is engaged in the impact assessment process concerning the Rose Lithium-Tantalum Project. The environmental impact statement for the Project was deemed complete by the Canadian Environmental Assessment Agency (now the Impact Assessment Agency of Canada) in March of 2019. Consultation and assessment by governmental authorities including the COMEX are taking place.

Critical Elements Lithium’s development strategy is based on a proven Management Team; a low risk two-phase approach; and a simple open pit mining and conventional processing operation. Phase 1 captures 70 percent of the value - Phase 1 production of spodumene concentrate and tantalum; Phase 2 production of lithium carbonate.

Critical Elements Lithium is contemplating different project capital expenditure (capex) funding solutions for the development and construction of Rose. The funding solutions undergoing consideration by the Company include Strategic Partnership, Offtake, Joint Venture (JV), Debt, and Equity.

Last week, Critical Elements Lithium announced the appointment of Mr. Eric Zaunscherb to its Board of Directors as an independent Director, effective immediately. Mr. Zaunscherb is a Canadian geologist with more than 32 years, and 6 cycles, of experience as a mining analyst. He most recently served as Managing Director, Research - Metals & Mining Analyst at Canaccord Genuity where he co-ordinated the firm's worldwide mining equity research team.

Critical Elements Lithium Corporation (CRECF), closed Wednesday's trading session at $0.1611, off by 1.7683%, on 91,286 volume with 11 trades. The average volume for the last 3 months is 14,281 and the stock's 52-week low/high is $0.1611/$0.474999994.

chart

Doubleview Capital Corp. (DBLVF)

Private Capital Newswire, Junior Mining Network, Streetwise Reports, InvestorX, OTC Markets, Big News Network, 8020 stocks, Central Charts, Stockhouse, GlobeNewswire, Dividend Investor, Wallet Investor, Seeking Alpha, GuruFocus, Morningstar, Stockwatch, 4-Traders, Mining Stock Education, Nasdaq, Newsfilecorp, Investing News, Barchart, Canadian Mining Report, TradingView and Simply Wall St reported beforehand on Doubleview Capital Corp. (DBLVF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Doubleview Capital Corp. identifies, acquires and finances quality base metal exploration mining projects in North America and more specifically the Province of British Columbia, Canada. The Company works to increase shareholder value via strategic and quality gold, copper, and silver projects acquisitions, and through advanced and state of the art exploration methods in the industry. Incorporated in 2008, Doubleview Capital lists on the OTC Markets and the Company is based in Vancouver, British Columbia.

Doubleview Capital’s projects include the Hat Deposit, Red Spring, and Mt. Milligan North. The Hat Property consists of 6,308.00 hectares in ten mineral tenures. It is in northwestern British Columbia in the Sheslay Valley, 95 km southwest of Dease Lake and 190 km south of Atlin. the Doubleview Capital Management and Geological team discovered the Hat deposit in early 2014 from a greenfield prospect in the first drilling season.

The Red Spring Copper-Silver-Gold property, situated 120 km north of Smithers, B.C., was discovered in 1972. Prior exploration was directed to a dolomitic limestone formation that carries finely disseminated silver-rich chalcopyrite. The property was drilled in the 1970s.

The Mt. Milligan North property has an area of 1,843 hectares. It is situated 165 km northwest of Prince George, British Columbia, in proximity to the Mt. Milligan copper-gold mine that is presently undergoing pre-production development. The Mt. Milligan North mineral tenures are situated in volcaniclastic rocks of Middle Triassic to Lower Jurassic age in Quesnellia terrane of the Intermontane physiographic belt of interior British Columbia, five to seven km north-northwest of the Mt. Milligan mine site where a copper-gold mine with 60,000 tonnes per day capacity is being readied for production.

This month, Doubleview Capital announced the latest assay results from its Hat Gold-Copper Porphyry property positioned in northwestern British Columbia. The Company states that additional analytical results will be announced when received from the laboratory and have been added to the Hat database.

Core samples from drill holes H026 and H031 extend the Lisle Zone mineralization to the south and at depth with strong gold and copper values and important silver, cobalt and palladium. Drill hole H026 was successfully deepened so as to probe what appeared from geophysical data to indicate the vertical continuation of the Lisle Zone. H026 has now extended the Zone to 900 meters from surface. It has confirmed the reliability of the 3D induced polarization survey data. H031 was collared 215 meters south of previous drill holes (550m southwest of drill hole H023) and extended the north-south dimension of the Lisle Deposit to 820 meters.

Doubleview Capital Corp. (DBLVF), closed Wednesday's trading session at $0.0402, even for the day, on 100,000 volume. The average volume for the last 3 months is 8,088 and the stock's 52-week low/high is $0.040199998/$0.126579999.

chart

InterCure Ltd. (IRCLF)

Stock Target Advisor, BioSpace, Profit Confidential, OTC Markets, PredictWallStreet, TeleTrader, AlphaBetaStock, Stockwatch, Wallet Investor, Stockhouse, Macroaxis, Tiingo, Barchart, Cannabis Stock Trades, TipRanks, GuruFocus, CalMarijuanaPolicy.org, TradingView, Morningstar, Dividend Investor and YCharts reported beforehand on InterCure Ltd. (IRCLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and globally. The Company’s wholly-owned subsidiary is Canndoc. This subsidiary has been pioneering Pharma-Grade medical cannabis for more than 11 years. Formed in 1994, InterCure is based in Israel. The Company’s shares trade on the OTC Markets.

The Canndoc subsidiary has provided over the years in excess of 500,000 doses to 15,000 patients. Canndoc has demonstrated substantial expertise across the entire value chain. This is from research, cultivation, and processing, to product development and advanced GMP (Good Manufacturing Practices) clinical trials pipeline initiation.

Canndoc delivers GMP Pharma-Grade cannabis solutions to realize better patient health and treatment outcomes. Canndoc's medicinal cannabis clinical pipeline includes late stage studies validating its GMP Pharma-Grade cannabis products for epilepsy, fibromyalgia, neuropathic pain, side effects of chemotherapy in cancer patients, Parkinson's disease, rheumatic arthritis, radicular pain, posttraumatic stress disorder (PTSD), and lumbar radiculopathy.

InterCure announced in November of 2019 that its Canndoc subsidiary initiated a Phase 3 clinical trial with the Shamir Medical Center (Assaf HaRofeh) for the treatment of children with autism spectrum disorder. The program will be led by Dr. Orit Stoller, a pediatric neurologist at the Autism Center at Shamir (Assaf HaRofeh), and Prof. Mati Berkovitch, Head of the Clinical Pharmacology Unit at the Shamir Medical Center (Assaf HaRofeh), validating the safety and efficacy of Canndoc's GMP Pharma Grade cannabis product T1/C20 for children with autism spectrum disorder. Assaf HaRofeh Medical Center is one of the largest leading government hospitals in Israel.

Earlier this month, Cellect Biotechnology Ltd. (NASDAQ: APOP) announced that its Board of Directors approved, and the company entered, subject to definitive agreements, into a commercial binding Letter Of Intent (LOI) with Canndoc Ltd., the aforementioned wholly owned subsidiary of Intercure. Cellect Biotechnology is a developer of unique technology that enables the functional selection of stem cells. Cellect will acquire from Canndoc all rights to the use of Canndoc products for the reduction of opioid usage, including accumulated data, and also on-going and pipeline of clinical trials.

Canndoc will supply Cellect, over the course of the next five years, with a minimum of 6 tons of GMP pharma grade cannabis products with a value of $18 million USD. Cellect will have the option to extend the agreement for an additional period of 5 years, until 2029.

InterCure Ltd. (IRCLF), closed Wednesday's trading session at $0.55, off by 3.5088%, on 150 volume with 1 trade. The average volume for the last 3 months is 3,104 and the stock's 52-week low/high is $0.300000011/$3.36999988.

chart

Mason Graphite, Inc. (MGPHF)

Stock Gumshoe, OTC Markets, ValueForum, PredictWallStreet, Wallet Investor, Capital Cube, Insider Financial, Macroaxis, Investing.com, Junior Mining Network, Resource World, StockInvest.us, Equity Clock, Market Screener, Stockhouse, PR Newswire, Streetwise Reports, InvestorsHub, TradingView and Investors Hangout reported previously on Mason Graphite, Inc. (MGPHF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Mason Graphite, Inc. is a graphite mining and processing company headquartered in Laval, Quebec. The Company is focusing on the development of the 100 percent owned Lac Guéret project located in northeastern Quebec. Company Management believes that Lac Guéret is one of the highest grade graphite deposits in the world. Mason Graphite is aiming to be one of the lowest cost producers in the world. A proven team with over 50 years of cumulative graphite experience, including processing knowledge and distribution capabilities leads Mason Graphite. The Company lists on the OTC Markets Group’s OTCQX.

Mason Graphite issued the positive results of an updated Feasibility Study (FS) for the Lac Guéret project in December of 2018. It featured a long life, low cost operation with an Internal Rate of Return (IRR) of 27.7 percent. The study considers only a portion of the total Measured and Indicated Mineral Resources.

"In-Pit" Mineral Resources beyond the Project Life of 25 years represents the ore looking to be extracted after the initial 25 years of mine life. This provides Mason Graphite with the flexibility of extending the mine life far beyond what was presented in the results of the FS. The Lac Guéret project consists of 215 claims covering 11,630 ha (116 km2).

Mason Graphite is also advancing a detailed study for large scale production of value-added graphite products that was started in 2015. Such second transformation includes micronization, additional purification, spheronization and coating, resulting in graphite products suitable for a wide variety of technical applications. This includes carbon brushes, brake linings, plastics and lubricants; electrochemical applications, and other specialized uses.

Mason Graphite announced in December 2019 positive test results in lithium ion cells for its anode material. The battery test results acquired on a pilot batch of spherical graphite for Li-ion batteries from Mason Graphite as part of a value-added product (VAP) development project are positive. The results confirm the hypothesis that the fine graphite flakes extracted from the Lac Guéret deposit are a suitable material to manufacture spherical graphite for the lithium-ion anode market, especially for electric vehicles.

In February, Mason Graphite announced that Mr. Benoit Gascon, President, Chief Executive Officer and Director, will retire, effective March 31, 2020. In addition, the Company announced the appointment of Mr. Peter Damouni as Director of the Corporation. Mr. Damouni has more than 18 years of experience in investment banking and capital markets, with expertise in natural resources. He is a Director of several companies listed on the TSX, TSX-V and London Stock Exchange.

Mason Graphite, Inc. (MGPHF), closed Wednesday's trading session at $0.1179, up 25.1061%, on 82,808 volume with 27 trades. The average volume for the last 3 months is 101,265 and the stock's 52-week low/high is $0.075000002/$0.327800005.

chart

GBT Technologies, Inc. (GTCH)

Zacks, OTC.Watch, VentureLine, last10k, Wallet Investor, Investing.com, Investors Hangout, Simply Wall St, Stockhouse, InvestorsHub, Nasdaq, Stockwatch, Street Insider, Market Screener, Investor Ideas, GlobeNewswire, TipRanks, GuruFocus, and OTC Dynamics reported previously on GBT Technologies, Inc. (GTCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GBT Technologies, Inc. specializes in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies. A development-stage enterprise, it has a portfolio of Intellectual Property (IP) that, upon commercialization, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. The Company previously went by the name Gopher Protocol, Inc. It changed its name to GBT Technologies, Inc. in August of 2019. Established in 2009, GBT Technologies is headquartered in Santa Monica, California.

The Company’s system foresees the creation of a worldwide mesh network. The heart of the system will be its advanced microchip technology that can be installed in any mobile or fixed device globally. GBT Technologies envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing, and enhanced mobile features as an alternative to traditional carrier services.

GBT’s Core Technology is a pioneering new platform with products that will change the way people interact with technology and each other. The Platform Technology is named GopherInsight™. It uses “public” RF spectrum to facilitate a private network between enabled devices. Products that use GopherInsight™ can have network access without using traditional Bluetooth, Cellular or Satellite connectivity.

GBT Technologies’ patent application for its secured communication integrated microchip (IC), GopherInsight™, protects unique integrated circuit technology targeted to be installed on IoT/mobile devices. The GopherInsight™ IC uses its own private network and satellite communications-based protocol to connect with other GopherInsight™ ICs in other IoT/mobile devices worldwide. The design of the circuits and its associated systems are to be communication protocol-aware and able to self-adjust in real time.

Recently, GBT Technologies announced it received an innovative opinion for its 3D microchip patent. The patent authority, which manages the international research report, stated that the claims are novel and non-obvious. A positive opinion is a professional examiner’s analysis of the patent’s claims.

The Company's 3D microchip patent is protecting GBT's futuristic integrated circuit technology that introduces new systems and methods for IC manufacturing. The invention presents new die structure and orientation, especially designed for deep nanometer range.

GBT Technologies plans to use the 3D integrated circuit technology for advanced GPUs and CPUs, and especially for AI/machine learning ICs, because they require a massive amount of smart circuitry. In addition, this invention is targeted to enable larger IoT/Mobile chips that include additional units on board like memory, analog, as well as RF circuitry.

GBT Technologies, Inc. (GTCH), closed Wednesday's trading session at $0.029, up 107.1429%, on 5,455,629 volume with 452 trades. The average volume for the last 3 months is 352,966 and the stock's 52-week low/high is $0.009499999/$46.00.

chart

CarSmartt, Inc. (CRSM)

InvestorBrandNetwork, FortuneNewsWire, StockPulse, Trader Newswire, TipRanks, Street Insider, OTC Markets, OTC Dynamics, Seeking Alpha, Simply Wall St, Morningstar, GuruFocus, last10k, PR Newswire, Dividend Investor, Wallmine, Investors Hangout, Stockopedia, Nasdaq, Wallet Investor, TradingView, Stockhouse, InvestorsHub, Global Banking and Finance Review, GlobeNewswire, and Dividend Investor reported earlier on CarSmartt, Inc. (CRSM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CarSmartt, Inc. is an American transportation network company (TNC) offering a peer-to-peer ridesharing service. Its platform can be accessed through its mobile app (Android and iOS). The Company formerly went by the name Sports Supplement Group, Inc. It changed its corporate name to CarSmartt®, Inc. in February of 2018. The Company serves markets in the Southeast region of the United States. CarSmartt has its head office in Coral Gables, Florida. The Company lists on the OTC Markets.

All CarSmartt drivers are subject to background checks to reassure the safety of the Company’s passengers. CarSmartt’s application is made to connect drivers with the world's travelers to make long-distance trips affordable. CarSmartt provides ridesharing services to users via their App at app.carsmartt.com.

CarSmartt’s mission is to democratize mobility and create a liberated ecosystem for road transportation. This means being more economic for drivers, and also efficient, transparent, eco-friendly, and higher earnings for drivers.

CarSmartt announced in May of 2019 the completion of the new Carsmartt App (iOS and Android). The platform has many features that enable CarSmartt's drivers to earn more money and allow riders to save more on fares.

Every driver who wants to work with CarSmartt needs to log in to the GoodHire site and submit their information by way of a link that will be posted on the Company’s website. This ensures third party verification of CarSmartt drivers and increases the level of security considerably.

Recently, CarSmartt announced its user growth and its start of development on its new "YouSmartt" service. YouSmartt will provide, for all CarSmartt participants, access to a proprietary network of up to 45 discounted ancillary offerings. This will include, but is not limited to, the areas of Beauty, Home Care, Auto Care, Pet Care, Child Care, Personal Care, Education, Technology Services, Entertainment, Travel, and Leisure.

CarSmartt, Inc. (CRSM), closed Wednesday's trading session at $0.0125, up 66.6667%, on 292,200 volume with 14 trades. The average volume for the last 3 months is 466,808 and the stock's 52-week low/high is $0.004699999/$0.194999992.

chart

Spearmint Resources, Inc. (SPMTF)

Investing News, InvestorX, MarketSmart Resources, Morningstar, Geology for Investors, Investment Pitch, 4-Traders, Stockwatch, Junior Mining Network, Wallet Investor, Stockhouse, MarketWatch, Trading View, and Dividend Investor reported previously on Spearmint Resources, Inc. (SPMTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Spearmint Resources, Inc. acquires, explores, and evaluates mineral properties in the USA and Canada. An exploration stage enterprise, its emphasis is on assembling a portfolio of low risk, high reward properties at the exploration stage and developing them to maximize shareholder value. The Company previously went by the name Indefinitely Capital Corp. It changed its name to Spearmint Resources, Inc. in February of 2012. Spearmint Resources is based in Vancouver, British Columbia (BC).

The Company’s current projects include a portfolio of prospects in the Golden Triangle of BC; the 'Golden Triangle Gold Prospects' comprising six claims consisting of 9,157 acres bordering GT Gold Corp, the 920 acre 'NEBA West' & 6,803 acre 'NEBA' Gold-Copper Prospects bordering Aben Resources Ltd, the 'Henry' Gold-Copper Prospect comprising two contiguous claim blocks totaling 4,912 acres in the direct vicinity of Golden Ridge Resources Ltd., and the 17,593 acre 'EL North' Nickel-Copper Prospect comprising six contiguous claims in the Eskay Creek Camp bordering Garibaldi Resources Corp. Its current projects also include its earlier acquisition, the 4,980 acre 'Prickle' property bordering Brixton Metals Corp.

Additionally, current projects include the 'Chibougamau Vanadium Prospects' comprising 17,142 contiguous acres bordering the vanadium deposit of BlackRock Metal's (private) Ilmenite vanadium project and Vanadium One Energy Corp. and Spearmint's 'Clayton Valley Lithium Prospects' in Nevada comprising two claim blocks totaling 1,160 acres bordering Pure Energy Minerals & Cypress Development Corp. where Spearmint's drill results have intersected Lithium values as high as 1,670 ppm Li.

Spearmint Resources’ other BC projects include the 'Gold Mountain Prospects' comprising three separate claim blocks totaling 1,245 acres bordering Barkerville Gold Mines, the 'Safari' Copper-Gold Prospect comprising 9,007 contiguous acres in the northern Quesnel Trough in north-central BC directly bordering Serengeti Resources, Inc., and the 'Hammernose' Gold Prospect consisting of 5,140 acres directly bordering the strategic alliance between Westhaven Ventures, Inc. & Sable Resources Ltd. in the Spences Bridge Gold Belt in Southern BC.

Spearmint Resources acquired the 'El North 3' claims package last year. This acreage will result in a contiguous land package totalling 17,593 acres bordering Garibaldi Resources Corp. in the Golden Triangle of BC.

In September 2019, Spearmint Resources announced that it acquired the Perron-East Gold Prospects consisting of 4 mineral claim blocks encompassing 2,862 acres situated in the Abitibi greenstone belt of northwestern Quebec. The newly acquired Perron-East Gold property covers prospective ground for orogenic gold and polymetallic VMS-(volcanogenic massive sulphide)-style mineralization in an area well known for its gold occurrences and historical production. Moreover, at the end of October 2019, Spearmint Resources announced that it encountered positive indicators on its "Safari" copper-gold prospect in the northern Quesnel Trough in north-central British Columbia.

Spearmint Resources, Inc. (SPMTF), closed Wednesday's trading session at $0.03, up 50.00%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 26,945 and the stock's 52-week low/high is $0.007/$0.075699999.

chart

Predictive Technology Group, Inc. (PRED)

NetworkNewsWire, Zacks, InvestorsHub, Insider Financial, Wallet Investor, Stockhouse, Wallmine, Infront Analytics, The Street, StreetWise Reports, Dividend Investor, and Simply Wall St reported earlier on Predictive Technology Group, Inc. (PRED), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Predictive Technology Group, Inc. is a therapeutics and life sciences company headquartered in Salt Lake City, Utah. It is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through inventive novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The Company formerly went by the name Global Enterprises Group, Inc. It changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group lists on the OTC Markets.

The Company’s wholly-owned subsidiaries are Predictive Therapeutics and Predictive Biotech. Through these, it focuses on four primary clinical categories. These are Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Laboratories concentrates on clinical and discovery work for human infertility and genetic conditions affecting women and children. Testing is performed using state-of-the-art instrumentation at its CAP and CLIA accredited facility.

Further to Predictive Biotech’s efforts to advance regenerative medicine, Predictive Therapeutics’ dedication is to assisting women in overcoming the devastating consequences of endometriosis through appropriate early-stage diagnosis and subsequent treatment. Subsidiary Predictive Biotech is a leader in human cell and tissue products for use in regenerative medicine. A growing national network of clinics, health systems, researchers and physicians take advantage of Predictive Biotech’s four main placental-derived and Wharton’s jelly umbilical cord-derived products (AmnioCyte™, AmnioCyte Plus™, PolyCyte™, CoreCyte™).

Predictive Technology Group recently announced that its wholly-owned subsidiary, Predictive Laboratories, reached an enrollment milestone of 200 participants in its ongoing Institutional Review Board (IRB)-approved study of spine and joint disease leading to chronic pain. Predictive Laboratories is the sponsor of the study. Kenneth Ward, MD, Laboratory Director of Predictive Laboratories, serves as Principal Investigator.

The primary objective of the IRB study is to conduct genetic research related to healthcare advancement in the diagnosis, treatment and prevention of conditions causing chronic pain. The first 200 participants have volunteered for the study by submitting their DNA samples to the Predictive Biorepository and by reporting detailed medical information through their healthcare providers.

Recently, Predictive Technology announced the signing of a letter of intent (LOI) with IQVIA (Formerly Quintiles and IMS) to guide the regulatory strategy for its wholly-owned subsidiary Predictive Biotech. The collaboration will expedite the process of identifying and executing the appropriate regulatory pathways for the Company’s existing products and future product candidates.

Predictive Technology Group also recently announced that Douglas S. Rabin, MD, has joined Predictive Laboratories as Vice President of Medical Affairs, Women’s Health. In this newly created position, Dr. Rabin will provide critical medical affairs support for the women's health clinical franchise. He has over 25 years of experience in women's healthcare. This includes clinical reproductive endocrinology, and obstetrics and gynecology.

Mr. Bradley Robinson, Predictive Technology Group Chief Executive Officer, said, “We welcome Dr. Rabin to the Predictive team to support our goal of commercializing our innovative, genetic-based diagnostics that are initially focus on human infertility and women’s health. Dr. Rabin is highly accomplished in launching pharmaceutical and diagnostic products at Fortune 500 companies. His experience and commitment to delivering improved, more comprehensive healthcare to patients will be of tremendous assistance in supporting our mission of employing advanced molecular diagnostics to prevent or eliminate disease for generations to come.”

Predictive Technology Group, Inc. (PRED), closed Wednesday's trading session at $1.03, up 70.2479%, on 6,830,353 volume with 3,128 trades. The average volume for the last 3 months is 538,675 and the stock's 52-week low/high is $0.368750005/$6.90999984.

chart

Smoke Cartel, Inc. (SMKC)

NetworkNewsWire, Stockwatch, 4-Traders, InvestorsHub, The Street, Penny Stock Hub, Stock News Feed, Wallmine, OTC Markets, Stockhouse, Street Insider, Investors Hangout, Dividend Investor, Trading View, MarketWatch, GlobeNewswire, Stockopedia, Wallet Investor, GuruFocus, and Morningstar reported earlier on Smoke Cartel, Inc. (SMKC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Smoke Cartel, Inc. is a top online retailer and wholesaler of glass water pipes, vaporizers, and other related accessories for the cannabis industry. In 2014, the Company commenced operations in the State of Georgia. It was formerly known as Lemont, Inc. In August 2017, it changed its corporate name to Smoke Cartel, Inc. Smoke Cartel is headquartered in Savannah, Georgia and lists on the OTC Markets.

Smoke Cartel operates in varied verticals within the online headshop industry. This consists of, but is not limited to, the sales of consumer products via online retail, sales of wholesale products to other retailers, the design and manufacturing of branded products, and shipping and fulfillment services. The Company’s retail division has greater than 90,000 customers in 44 nations.

Smoke Cartel earlier acquired and undertook the integration of UPC Distribution into Glassheads Distribution, the wholesale division of Smoke Cartel. It then rebranded its Glassheads Distribution division as Smoke Cartel Wholesale. Furthermore, it acquired and integrated Early Bird Distribution and all of its brands. Therefore, this expanded Smoke Cartel into new markets, such as the pet industry.

Smoke Cartel has covered a wide niche of glassware. The Company’s plan is to focus on non-glass products and accessories in the future to expand product selection and to reach new markets. Smoke Cartel currently has nine branded product lines to serve diverse demographics in the smoking accessory marketplace.

Smoke Cartel has launched AskVape.com. This is a one-stop online vape shop. The site offers vaporizers, e-juice, vape parts, and accessories all in one convenient location.

Recently, Smoke Cartel announced that it re-released MidnightToke.com as a female-friendly cannabis culture storefront. MidnightToke.com was bought with a bundle of domains as part of a KushCo Holdings, Inc. purchase agreement in 2018. Midnight Toke has undergone re-launch to capture the attention of female cannabis consumers.

Smoke Cartel has released WeedAlmighty.com as a cannabis content and gaming platform. WeedAlmighty.com is the Company’s latest website launch. It centers on a trendy cannabis audience through using astute plays on common-use online gaming and modern content news. WeedAlmighty is a new place in the industry for the latest cannabis news, cannabis lifestyle information, as well as culture articles.

Smoke Cartel, Inc. (SMKC), closed Wednesday's trading session at $0.065, up 237.6623%, on 3,675 volume with 7 trades. The average volume for the last 3 months is 2,960 and the stock's 52-week low/high is $0.019249999/$1.00.

chart

Black Cactus Global, Inc. (BLGI)

StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.

The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.

In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.

In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.

Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.

Black Cactus Global, Inc. (BLGI), closed Wednesday's trading session at $0.0055, up 52.7778%, on 40,072 volume with 9 trades. The average volume for the last 3 months is 119,741 and the stock's 52-week low/high is $0.001/$0.026499999.

chart

Black Ridge Oil & Gas, Inc. (ANFC)

TopPennyStockMovers, Wall Street Resources, and Wall Street Reporting reported earlier on Black Ridge Oil & Gas, Inc. (ANFC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Black Ridge Oil & Gas, Inc. is a growth-oriented oil and gas exploration and production enterprise. The Company is concentrating on non-operated Bakken and Three Forks properties.  At present,  it controls more than 10,000 net Bakken and/or Three Forks acres. Established in 2010, Black Ridge Oil & Gas is headquartered in Minnetonka, Minnesota. The Company lists on the OTC Markets Group’s OTCQB.

On June 21, 2016, Black Ridge Oil & Gas closed its debt restructuring agreement. It remains a public company. Its strategy shifted from asset owner to asset  Manager.

Black Ridge Oil & Gas, along with its capital providers, is working to acquire oil and gas assets throughout the major U.S. onshore basins. Since 2010, it has participated in drilling greater than 300 Bakken or Three Forks wells in North Dakota and Montana.

The Company receives short term income from management fees from the different joint ventures (JVs) - Black Ridge Holding Company, LLC initially; Merced Black Ridge, LLC (established July 2015), and others as it makes acquisitions.

In essence, Black Ridge Oil & Gas concentrates on its asset management business and partnering with investment sponsors to acquire oil and gas assets. Moreover, the Company concentrates on energy loans and providing capital for oil and gas drilling/completion projects. 

Black Ridge Oil & Gas takes a minority rather than majority interest in its wells. This strategy produces a highly-diversified portfolio of Bakken and Three Forks wells across the Williston Basin for the Company.

Black Ridge currently manages Working Interests (WIs) in more than 350 gross Bakken and/or Three Forks wells. These produce roughly 1,500 net BOEPD  (Barrels of Oil Equivalent Per Day). 

Black Ridge (being a non-operator) participates in Bakken and Three Forks wells on a proportionate basis. This is according to its leasehold interest in each drilling unit drilled by its operating partners. 

The Company, as sponsor of Black Ridge Acquisition Corp. (BRACU), is aggressively looking to acquire oil and gas assets throughout the major United States basins. Black Ridge Acquisition is a $138 million special purpose acquisition company (SPAC) focused on identifying a growth oriented merger candidate.

Regarding its Merced Black Ridge Partnership, Merced provides equity capital. This capital is used to acquire/develop non-operated assets in all U.S. onshore basins. Black Ridge sources deals and manages day to day business.

Black Ridge Oil & Gas, Inc. (ANFC), closed Wednesday's trading session at $2.98, up 49.00%, on 1,423 volume with 11 trades. The average volume for the last 3 months is 221 and the stock's 52-week low/high is $1.74100005/$12.00.

chart

Paratek Pharmaceuticals, Inc. (PRTK)

Nickerson News, BioPharmCatalyst, Zacks, Newsheater, StockNews, BOVNews, Street Insider, Dividend.com, DBT News, Stockwatch, Investors Observer, Market Screener, Simply Wall St, Stocktwits, ETF.com, Seeking Alpha, Nasdaq, TradingView, Stockhouse, YCharts, Equities.com, Morningstar, CSI Market, MacroTrends, Investing.com, Barchart, Dividend Investor, InvestorsHub, ETF Channel, Ceo.ca and Investor Welcome reported earlier on Paratek Pharmaceuticals, Inc. (PRTK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts. It concentrates on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. The Company focuses on drugs that target infectious disease and other difficult to treat conditions. Its lead commercial product is NUZYRA® (omadacycline). Established in 1996, Paratek Pharmaceuticals lists on the NasdaqGM.

Last year, the Company was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA) to support the development of NUZYRA for the treatment of pulmonary anthrax. NUZYRA is a once-daily oral and intravenous antibiotic. It is available in the United States for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Paratek Pharmaceuticals has a collaboration agreement with Zai Lab (Shanghai) Co., Ltd. This agreement is for the development and commercialization of omadacycline in the greater China region. Paratek retains all remaining worldwide rights.

Additionally, Paratek Pharmaceuticals exclusively licensed U.S. rights and rights to the greater China territory for SEYSARA® (sarecycline) to Almirall, LLC. Paratek retains the development and commercialization rights for sarecycline worldwide. SEYSARA is a once-daily oral therapy for the treatment of moderate to severe acne vulgaris. The FDA (Food and Drug Administration) approved SEYSARA in October of 2018 for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.

Last month, Paratek Pharmaceuticals announced it entered into a license grant with Almirall (ALM) for SEYSARA for the greater China region. This includes the Peoples Republic of China (PRC), Hong Kong, and Macau. With this agreement, Paratek will earn high single-digit royalties on net sales in the greater China region. Almirall plans to develop sarecycline for acne in China, with a potential submission to the China National Medical Products Administration in 2023.

This month, Paratek Pharmaceuticals announced that a pre-emergency use authorization (EUA) application for NUZYRA (omadacycline) was submitted to the FDA. With a pre-EUA, the FDA could allow for the potential use of NUZYRA during a declared emergency under emergency use authorization for the treatment and prophylaxis of pulmonary anthrax in a public health emergency.

Paratek Pharmaceuticals, Inc. (PRTK), closed Wednesday's trading session at $3.16, off by 1.25%, on 611,001 volume with 4,002 trades. The average volume for the last 3 months is 976,822 and the stock's 52-week low/high is $2.50/$6.38999986.

chart

The QualityStocks Company Corner

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Tuesday reported its financial and operational results for the fourth quarter and full year ended December 31, 2019. Among other highlights, the company reported that revenue for the full year of 2019 totaled $402,000, and that $133,000, or 33% was earned in the fourth quarter. To view the full press release, visit http://nnw.fm/V4PGs. Also today, SGLB announced it has changed the format of its special stockholders meeting from a physical in-person meeting to a virtual webcast in response to the current situation regarding the public health impact of the COVID-19 pandemic. To view the full press release, visit http://nnw.fm/8GktB. Additionally, NetworkNewsWire released a report highlighting the company which examines the recent news that the full promise of 3D metal printing is imminent as long-sought quality-control systems provide newfound ability to scale additive metal manufacturing.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Wednesday's trading session at $2.87, up 8.3019%, on 817,393 volume with 4,303 trades. The average volume for the last 3 months is 74,329 and the stock's 52-week low/high is $2.18109989/$18.50.

Recent News

chart

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. To view the full press release, visit http://cnw.fm/j8EYD

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Wednesday's trading session at $0.35, up 14.75%, on 1,657,514 volume with 245 trades. The stock's 52-week low/high is $0.305/$0.34.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a revolutionary new class of hemp extract infusion technologies designed to make hemp infusions simple for both small and large beverage manufacturers. According to the update, the company’s EZ Hemp Infusions product line is based on patented and patent pending 100% water-soluble technology enabling ultra-low doses to hemp extracts and cannabinoids to be utilized. To view the full press release, visit http://cnw.fm/U2mfD. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. In late 2019, the novel Coronavirus, dubbed COVID-19, first appeared in Wuhan, China, and the country literally ground to a halt. The most hard-hit regions went into lockdowns to prevent the spread of the virus, but it also drastically reduced the county’s manufacturing output. Since China is a known low-cost producer, tons of industries were affected by this disruption in manufacturing, including the cannabis sector.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Wednesday's trading session at $0.27, up 43.617%, on 2,060 volume with 5 trades. The average volume for the last 3 months is 15,420 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Bolt Metals Corp. (OTCQB: PCRCF).

Mineral exploration company Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) works consistently toward carrying out its corporate strategy in 2020 as it continues to set ambitious milestones to create significant long-term shareholder value and become a leading international player in the electric vehicle battery metal sector. This includes preparations to commission and operate a pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Bolt Metals Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Bolt Metals well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Bolt Metals, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Bolt Metals’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Bolt Metals is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Bolt Metals Corp. (OTCQB: PCRCF), closed Wednesday's trading session at $0.11045, up 5.1905%, on 40,965 volume with 30 trades. The average volume for the last 3 months is 51,215 and the stock's 52-week low/high is $0.079999998/$0.355599999.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

As the energy drink craze is beginning to die down amid health concerns for the industry’s overly sugary and ultra-caffeinated reputation, consumers are searching for a healthier beverage to give their brains a boost. Enter nootropic beverages: the newest “smart drink” to hit the shelves has been met with an enthusiastic consumer response (http://nnw.fm/Y8yLN). Sharing Services Global Corporation’s (OTCQB: SHRG) two-day pre-sale for its ElevaciTEA(TM) – a first-of-its-kind nootropic addition to the company’s functional beverage line – has illustrated consumers’ desire for the new category of functional beverages. Also today, the company provided an update regarding its safety measures and status of operations, “In this time of challenge and uncertainty, I wanted to share with you some of the measures that we have implemented as a company in order to continue our mission of enhancing the lives of our customers and commercial relationships through the sale of our health and wellness products.”

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Wednesday's trading session at $0.04111, up 17.4571%, on 1,542,400 volume with 28 trades. The average volume for the last 3 months is 398,392 and the stock's 52-week low/high is $0.0215/$0.3944.

Recent News

chart

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Wednesday's trading session at $0.0295, up 9.1582%, on 3,235 volume with 5 trades. The average volume for the last 3 months is 24,655 and the stock's 52-week low/high is $0.009999999/$0.07.

Recent News

chart

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies Inc. (TSX.V: ISGI) (ISGI Profile) is a SaaS (Software-as-a-Service) company leading the way on insurtech integration, with a software platform that covers both insurance and the technology mechanisms to book that insurance in the hospitality industry.

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.

InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protection that Enhances the Guest’s Experience

InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Wednesday's trading session at $0.14, even for the day, on 6,000 volume. The average volume for the last 3 months is 12,627 and the stock's 52-week low/high is $0.07/$0.100000001.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Tuesday announced that its Chief Executive Officer, Chris Bunka, will present live at LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s presentation is scheduled to begin at 12:00 PM ET. The live, interactive online event invites investors to ask the company questions in real-time. To register and view event details, visit http://cnw.fm/t9NR1. To view the full press release, visit http://cnw.fm/jQ397

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.3074, up 2.4667%, on 114,160 volume with 71 trades. The average volume for the last 3 months is 117,863 and the stock's 52-week low/high is $0.229499995/$1.34000003.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, announced today that, due to market conditions, it is adapting operations and aggressively reducing costs. Valleyfield Cost Savings. The Company has postponed the start up of its Valleyfield facility in order to centralize cultivation operations at Ancaster.  The Ontario facility is able to produce larger volumes than initially anticipated, enabling the Company to delay cultivation operations in Valleyfield saving costs and capital. The Company has temporarily laid off the majority of its Valleyfield employees and intends to restart operations there later in the year. Ancaster is not impacted and continues to grow and harvest premium organic cannabis for the recreational and medical markets.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $0.2275, up 8.3333%, on 1,839,269 volume with 457 trades. The average volume for the last 3 months is 1,151,608 and the stock's 52-week low/high is $0.150000005/$3.78999996.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) on Tuesday announced that its board of directors has appointed Stephen Brown as the president, chief executive officer and as a director of the company and Mark Groenewald as the chief financial officer of the company, effective immediately. In addition, the common shares in the capital of Wonderfilm Media Corporation will be reinstated to trading on the TSX Venture Exchange on March 26, 2020. To view the full press release, visit http://nnw.fm/Di3mE

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Wednesday's trading session at $0.07, even for the day, on 23,500 volume. The average volume for the last 3 months is 23,961 and the stock's 52-week low/high is $0.07/$0.25999999.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders (OTC: NBDR) today announced that it has amended its existing SEC Qualified Reg A offering to dramatically cut the number of authorized shares available from 300,000,000 to 100,000,000 while increasing the offering price per share from $0.01 per share to $0.03 per share, effective immediately. To view the full press release, visit http://ccw.fm/tTHb6

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Wednesday's trading session at $0.0386, off by 19.5833%, on 16,823,682 volume with 1,402 trades. The average volume for the last 3 months is 2,078,986 and the stock's 52-week low/high is $0.008299999/$0.089000001.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $0.17, up 13.2578%, on 804,660 volume with 351 trades. The average volume for the last 3 months is 544,283 and the stock's 52-week low/high is $0.101000003/$1.74.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $2.175, up 11.5385%, on 12,072 volume with 32 trades. The average volume for the last 3 months is 18,773 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $1.54, up 7.3171%, on 279,850 volume with 834 trades. The average volume for the last 3 months is 471,081 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.